A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
Abroad (travel likely)RecruitingPHASE1
Conditions
Healthy Volunteers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Acpru /Id# 279789, Grayslake, Illinois, United States
Study leads
ABBVIE INC.
Study Director
AbbVie